McAdam LLC’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

McAdam LLC’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,453	Closed	-$4.91K	–	272
2023 Q2	$4.91K	Buy	+16,453	New	+$4.96K	﹤0.01%	263

McAdam LLC's GRNA Position: Q3 2023 in Review

McAdam LLC sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 16,453 shares — an estimated $4.91K sold.

McAdam LLC first reported a position in GRNA in Q2 2023 and held it in 1 quarter. The position peaked at $4.91K in Q2 2023. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

McAdam LLC reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
McAdam LLC sold 16,453 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $4.91K.
McAdam LLC first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2023 and held it in 1 quarter.
McAdam LLC's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $4.91K in Q2 2023.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on McAdam LLC's 13F filing for Q3 2023, filed 31 Oct 2023.